Products
AESARA HEOR Benchmarking Report: 2024
Insights on how Biopharma companies rank among their peers, strengths and weaknesses of HEOR organizations, and areas for improvement in value and evidence generation to enable patient access |
Rationale
- Capability
Health Economics and Outcomes Research (HEOR) in the biopharmaceutical industry has grown significantly in recent decades, emphasizing patient access to new medicines alongside regulatory approvals
- Environment
Increasing investments in HEOR capabilities are driven by stakeholder demands for timely evidence of product value worldwide
Additionally, policy developments like the Inflation Reduction Act (IRA) and European Union Regulation on Health Technology Assessment (EU HTAR) necessitate flexible and updated responses from HEOR functions
- Need
To maintain efficiency and sustainability, HEOR Groups must optimize their structure, evidence generation efforts, and marketplace impact
Benchmarking studies are an important input to HEOR future-proofing strategies; however, the most recent studies focused on Medical Affairs and Market Access and only had some HEOR components
This 2024 benchmark is based on qualitative and quantitative data from:
7
biopharmaceutical companies
60+
interviews conducted with HEOR leaders and team members worldwide
Interviewee representation from:
Global
US
EU
Japan
Canada
UK
Focus
Organization structure
and positioning
- Overview of participating companies
- Centralized vs decentralized structure
- Company positioning: Clinical/Medical vs Commercial/Corporate
- Dedicated US support
- HEOR geographic markets
- C-suite expectations
- Dedicated TA leads
- Platform functions and CoEs
- Outsourcing HEOR studies
- Organizational restructuring
Capabilities
and infrastructure
- Budget
- Core capabilities
- Participation on Global/US
- Product/Brand Teams
- Value narrative support
- SOPs/guidances
- ICER engagement
- AI and technology advancements
- Policy and methods developments
Teams
characteristics
- FTE per $B revenue
- FTE per drug development phase
- HEOR Team qualifications
- Professional development
- Titles and salaries
- Reporting layers
- Remote work
Ways of
working
- Global/Local interactions
- Cross-functional group interactions
- Evidence generation planning
- RWE
- External stakeholders interactions
- HEOR metrics
- Role of professional societies
AESARA insights and
recommendations
Investment will include access to a final report including organization structure and positioning, team characteristics, capabilities and infrastructure, ways of working, AESARA insights, and recommendations
